APA

Patriarca F., Medeot M., Isola M., Battista M. L., Sperotto A., Pipan C., Toffoletti E., Dozzo M., Michelutti A., Gregoraci G., Geromin A., Cerno M., Savignano C., Rinaldi C., Barbone F. & Fanin R. (20140121). Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. : Transplant infectious disease : an official journal of the Transplantation Society.

Chicago

Patriarca F, Medeot M, Isola M, Battista M L, Sperotto A, Pipan C, Toffoletti E, Dozzo M, Michelutti A, Gregoraci G, Geromin A, Cerno M, Savignano C, Rinaldi C, Barbone F and Fanin R. 20140121. Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. : Transplant infectious disease : an official journal of the Transplantation Society.

Harvard

Patriarca F., Medeot M., Isola M., Battista M. L., Sperotto A., Pipan C., Toffoletti E., Dozzo M., Michelutti A., Gregoraci G., Geromin A., Cerno M., Savignano C., Rinaldi C., Barbone F. and Fanin R. (20140121). Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. : Transplant infectious disease : an official journal of the Transplantation Society.

MLA

Patriarca F, Medeot M, Isola M, Battista M L, Sperotto A, Pipan C, Toffoletti E, Dozzo M, Michelutti A, Gregoraci G, Geromin A, Cerno M, Savignano C, Rinaldi C, Barbone F and Fanin R. Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. : Transplant infectious disease : an official journal of the Transplantation Society. 20140121.